Oncology News Archives

Researchers at Uppsala University and University Children's Hospital in Uppsala have devised powerful new tools for typing cells from children with acute lymphatic leukemia and for prediction of how children with leukemia will respond to chemotherapy.

The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment.

The number of Europeans dying from cancer fell by at least 8 percent in the first half of the decade, thanks largely to a decrease in smoking rates, researchers said .

Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials Article Date: 24 Nov 2009 - 1:00 PST Two recent FDA approvals have prompted the National Comprehensive Cancer Network to update the NCCN Clinical Practice Guidelines in Oncology for Non-Hodgkin's Lymphomas to include ...

New figures on deaths from cancer in Europe show a steady decline in mortality between the periods 1990-1994 and 2000-2004. Deaths from all cancers in the European Union between these two periods fell by nine percent in men and eight percent in women, with a large drop among the middle-aged population.

Ontario is extending its funding of a potentially life-saving drug for cancer patients, just two months after the province's ombudsman accused the government of verging on cruelty by cutting off funding after 16 treatments.

The information in this column is intended forA informational purposes only, and does not constitute medical advice or recommendations by the author.A Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.

24 November 2009 -Clavis Pharma ASA , the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase ...

Main Category: GastroIntestinal / Gastroenterology Also Included In: Pain / Anesthetics ; Cancer / Oncology ; Colorectal Cancer Article Date: 27 Nov 2009 - 0:00 PST A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical ...

Novartis has gained exclusive rights to two oral targeted investigational therapies for patients with a range of life-threatening blood disorders and cancers that currently do not have effective treatment options.

Dr. George Sledge is the Ballve-Lantero professor in the division of hematology/oncology at the Indiana University School of Medicine and a physician/ researcher with the IU Melvin and Bren Simon Cancer Center.

Main Category: Cancer / Oncology Also Included In: Urology / Nephrology Article Date: 25 Nov 2009 MDRNA, Inc.

Adding the drug cetuximab to neoadjuvant chemotherapy can shrink tumors and boost the odds of successful surgery in colorectal cancer patients with inoperable metastatic liver lesions, new research suggests.

Nov 24, 2009 - CombinatoRx, Incorporated today announced that two abstracts highlighting data on its A2A and Beta-2 Adrenergic Receptor Agonist oncology programs have been accepted for presentation at the American Society for Hematology 2009 Annual Meeting in New Orleans on December 5-8, 2009.

Main Category: Cancer / Oncology Also Included In: Immune System / Vaccines Article Date: 25 Nov 2009 The H1N1 vaccine has spurred media interest in vaccines, as well as predictions of vaccines for a host of new diseases.

An article published Online First in The Lancet Oncology reports that adding cetuximab to neoadjuvant chemotherapy can shrink tumours and lead to increased potentially curative surgery in patients who have colorectal cancer with inoperable metastatic liver lesions.

Standing up for other female doctors at the University of Pittsburgh Cancer Institute cost Dr.

Biotech startup Clovis Oncology Inc. has signed its first drug into its research pipeline, licensing an experimental pancreatic cancer treatment from a company in Norway.

Nov 25, 2009 - Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year.

Insomnia and sleep disorders affect more than three-quarters of cancer patients undergoing chemotherapy, a rate nearly three times higher than that of the general population, a new study finds.

The world of cancer screening has been upended in the past two weeks. Not only did the U.S. Preventive Services Task Force just raise the age at which it recommends women get their first mammogram from 40 to 50, but the American College of Obstetrics and Gynecologists decided that adolescents should be spared the inconvenience and possible risks of ...

A recent study shows that 95 percent of radiation oncologists use advanced imaging techniques such as positron emission tomography , magnetic resonance imaging , and 4-dimensional computed tomography for target delineation , according to an article in the December issue of the Journal of the American College of Radiology , . In defining the target, ...

Some worry these new guidelines will give many women an excuse not to get checked.

Main Category: Cancer / Oncology Also Included In: Sleep / Sleep Disorders / Insomnia Article Date: 24 Nov 2009 Researchers have found that 43 percent of patients undergoing chemotherapy for cancer in a clinical trial met the clinical criteria for insomnia syndrome and an additional 37 percent had insomnia symptoms, suggesting that the majority of ...

Christmas came early this year for one child from South Lyon. Battling terminal cancer, his parents asked for help to make his holiday wishes come true, and people from around the world sent their love and support.

Main Category: Melanoma / Skin Cancer Also Included In: Cancer / Oncology Article Date: 23 Nov 2009 Genta Incorporated announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company's lead oncology product, Genasense Injection, administered for the first time ...

Three quarters of cancer patients and survivors treated with chemotherapy suffer insomnia or sleep disorders that often become chronic conditions, hindering patients' ability to fully recover, according to scientists at the University of Rochester Medical Center.

WASHINGTON - Calm. That's not a word one hears much these days, but calm is what some are urging in the wake of a new federal report on breast cancer screening.

New recommendations on the use of chemotherapy to treat patients with stage 4 non-small cell lung cancer were issued today by the American Society of Clinical Oncology .

Main Category: Breast Cancer Also Included In: Cancer / Oncology Article Date: 19 Nov 2009 - 6:00 PST printer friendly view / write opinions Individualised radiotherapy treatment based on a person's genetic make up could soon become a reality, according to Breast Cancer Campaign.

Main Category: Lung Cancer Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials Article Date: 22 Nov 2009 - 1:00 PST The Committee for Medicinal Products for Human Use , the scientific committee of the European Medicines Agency , has adopted a negative opinion for the use of Erbitux in combination with ...

Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic ...

Published: Wednesday, November 18, 2009 at 12:41 a.m. Last Modified: Wednesday, November 18, 2009 at 12:53 a.m. LAKELAND A government task force's recommendation that most women delay having screening mammograms until age 50 and not bother with breast self-exams came as a bombshell to Dr.

Guidelines released Monday by the U.S. Preventative Services Task Force saying mammograms before age 50 and breast self-exams are unnecessary is bunk, says breast cancer survivor Suzanne Payne, 61, Appleton.

I understand the outrage over new federal guidelines suggesting a much more limited approach to screening women for breast cancer.

Main Category: Cancer / Oncology Also Included In: Ear, Nose and Throat Article Date: 18 Nov 2009 The American Society of Clinical Oncology has once again recognized Erbitux as one of the major clinical cancer advances of 2009.

The debate on how to select patients who will respond best to costly drug treatments for aggressive breast cancer now favors fluorescence in situ hybridization to measure the HER-2 receptor found in human breast tumors, according to a leading pathologist presenting at the Association for Molecular Pathology annual meeting.

Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors , despite such tumors being commonly considered resistant to radiation therapy, according to a largest of its kind study in the November 15 issue of the International Journal of Radiation Oncology*Biology*Physics , the official ...

By Brian Bethel Scripps Howard News Service While health care pundits debate over when women should have mammograms, 2,000 men diagnosed with breast cancer this year are in the shadows.

Dr. Raymond Facco says Parkview Comprehensive Cancer Center diagnosed 25 women under 50 with breast cancer this year.

Breast cancer is the 2nd leading cause of death amongst women in the United States and early detection is vital for treatment.

Family caregivers can significantly reduce suffering in cancer patients at home through use of simple touch and massage techniques.

Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort.

Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin directly into a patient's malignant brain tumor.

A group of local doctors say they'll still recommend mammograms and self-exams for their patients, despite new guidelines released this week by a government task force.

Local oncologists are fuming over the release of recommendations that would lead to fewer mammographies for women over the age of 40 if the medical profession were to adopt them.

Main Category: Breast Cancer Also Included In: Radiology / Nuclear Medicine Article Date: 19 Nov 2009 - 3:00 PST A radiation breakthrough to treat breast cancer patients in one day, as opposed to the current average of six weeks, has arrived at Cancer Treatment Centers of America in Philadelphia.

Comment about "First phase of Oncology Centre gets green light" Phone Name Comment 0 Thursday, 19th November 2009 - 11:40CET First phase of Oncology Centre gets green light The first phase of the construction of the Oncology Centre at Mater Dei Hospital was approved by the Mepa board this morning.

Main Category: Cancer / Oncology Also Included In: GastroIntestinal / Gastroenterology CytRx Corporation , a biopharmaceutical company, today announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric cancer.

U.S. Rep. Parker Griffith, D-Alabama, condemned on Wednesday the panel recommending that women delay a first mammogram until age 50 and get checkup every two years rather than annually.

The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered.

Main Category: Breast Cancer Also Included In: Cancer / Oncology Article Date: 17 Nov 2009 - 17:00 PST NCI appreciates the U.S. Preventive Services Task Force's careful review and analysis of the evidence regarding breast cancer screening for women at average risk.

A federal jury has convicted a Virginia Beach physician on nearly 30 counts in a fraudulent-billing scheme that bilked government health programs out of $1.2 million.

Despite new recommendations that most women start breast screening at 50 rather than 40, many doctors said Tuesday that they were simply not ready to make such a drastic change.

Doctors are in uproar over a recommendation to raise the age of breast cancer screening, saying that more women will die from the disease, which claims 40,000 lives each year.

In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue.

A Mid-South oncologist was instrumental in a clinical trial that will help women nationwide.

Some lawmakers on Capitol Hill are blasting new guidelines from a government task force that recommends against routine mammograms for women under 50, questioning whether they are tantamount to health care "rationing" in the fight against the No.

A diagnosis of breast cancer usually means having chemotherapy to stop the cancer coming back.

What: The International Association for the Study of Lung Cancer will hold an expert roundtable and Web cast announcing the recent publication and impact of the IASLC's Staging Manual in Thoracic Oncology containing the recently released 7th Edition of TNM in Lung and Pleural Tumours.

When Los Angeles Zoo veternarians diagnosed Randa the rhino with skin cancer, they realized they had a logistical problem on their hands.

The TiO2 nanoparticles induced single- and double-strand DNA breaks and also caused chromosomal damage as well as inflammation, all of which increase the risk for cancer.

To read this article in full you must have registered and have a Premium Content Subscription with the NHS Choices site.

LOS ANGELES Nov. 12, 2009 The change of the calendar from October to November doesn't mean breast cancer research and education comes to a stop.

Last month, the Vera Bradley Foundation for Breast Cancer finished a decadelong effort to donate $10 million to the Indiana University Melvin and Bren Simon Cancer Center.

The American Society of Clinical Oncology received the Northern Virginia Family Service CARE Award for their commitment to providing a family-friendly workplace for its employees.

Kareem Abdul-Jabbar, one of the greatest basketball players of all time, known for his unblockable signature "skyhook" shot, was diagnosed late last year with a rare type of blood cancer known as Philadelphia chromosome-positive chronic myeloid leukemia .

" AEterna Zentaris Inc. , a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.

The physicians of Oncology Alliance, which serves cancer and hematology patients in southeastern Wisconsin, are joining Aurora Advanced Healthcare.

Clinipace, a global technology-driven clinical research organization , announced today that on October 26th, 2009 the company closed its acquisition of Worldwide Clinical Research, Inc.

Evotec AG today announced that it has extended the research collaboration with Boehringer Ingelheim for a further 4 years.

Declining use of hormone replacement therapy may be driving down rates of a condition called "atypical ductal hyperplasia," a known risk factor for breast cancer, new research suggests.

A drug for people with a form of leukemia holds promise as a possible treatment for ovarian cancer, new research suggests.

New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of ...

Breast cancer is the second leading cause of cancer deaths worldwide, behind lung cancer, and it is the most common cancer among women.

A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.

The findings of this research really suck : When Seattle oncologist Dr. Marc Chamberlain was treating his brain cancer patients, he noticed an alarming pattern.

Main Category: Alcohol / Addiction / Illegal Drugs Also Included In: Cancer / Oncology IT / Internet / E-mail Article Date: 12 Nov 2009 Every time a person snorts cocaine, it doesn't just go to his or her head: It also provokes a response in the immune system, creating special biomolecules that may serve as a permanent record of each exposure.

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer .

An analysis conducted by the Finnish Breast Cancer Group and published in The Lancet Oncology shows women at intermediate to high-risk of early breast cancer recurrence who received capecitabine as part of their chemotherapy regimen had a 34% reduction in the risk of the disease returning or death, compared with those taking the chemotherapy ...

Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian ...

New Mayo Clinic research studied the association between prostate-specific antigen levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer.

Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed.

Optical technology could help physicians detect small colorectal polyps during colonoscopies and save money, too, new research suggests.

The American Society of Clinical Oncology released its report, Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention and Screening, an independent assessment of the most significant clinical cancer research studies of the past year, including 15 major advances.

Even three years after finishing treatment for breast cancer, almost 50 percent of women report long-term pain, a new Danish study finds.

A woman is six times more likely to be separated or divorced soon after a diagnosis of cancer or multiple sclerosis than if a man in the relationship is the patient, according to a study that examined the role gender played in so-called "partner abandonment." The study also found that the longer the marriage the more likely it would remain intact.

The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.

Human embryonic stem cells could help people with learning and memory deficits after radiation treatment for brain tumors, suggests a new UC Irvine study.

Aggressive tumors lacking p53 protein stop dead in their tracks when p53's sister protein -- TAp63 -- steps in Oncologists have had their hands tied because more than half of all human cancers have mutations that disable a protein called p53.

Two drugs used to treat breast cancer and osteoporosis eliminated cervical cancer in mice, according to a new study.

For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades.

Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack cancer cells will increase its share of a $48 billion oncology market.

Doctors have given actor SIMON MACCORKINDALE just three years to live after he was diagnosed with terminal cancer.

Main Category: Cancer / Oncology Also Included In: Clinical Trials / Drug Trials Article Date: 09 Nov 2009 An article published Online First in The Lancet Oncology reports that adding cetuximab to radiation therapy prolongs survival in patients with locally advanced head and neck cancer compared with radiotherapy alone.

Green tea extract has been found effective in preventing oral cancer, say researchers at The University of Texas M. D. Anderson Cancer Centre .

Two north central West Virginia hospitals have launched a joint fundraiser to benefit patient care and cancer research.

Men who receive a a oeboosta of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncologya s 51st ...

A vaccine that targets human papillomavirus is able to stop precancerous lesions in the vulva from progressing into full-blown malignancies, Dutch researchers report.

New Delhi, Nov 7 : About a decade back, the age group of women most vulnerable to breast cancer was 50 and above.

A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use.

Research has found that "nearly 40% of breast cancer tumours change form when they spread," BBC News reported.

Evidence continues to brew about the protective effects of green tea against cancer, but scientists are still not sure the tea leaves reveal the answer.

Nov. 2, 2009 - Stereotactic body radiation therapy should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians.

A shorter, more intense course of whole-breast radiation works as well as the traditional six-week course, at least for some early-stage breast cancers, a new study shows.

In a prospective study of more than 5,000 U.S. men, epidemiologists say they now have evidence that having lower levels of heart-clogging fat may cut a man's risk of this form of cancer by nearly 60 percent.

A brief course of hormone-blocking therapy can provide small benefits to a specific group of men who get radiation therapy for prostate cancer , a long-running study shows.

Another significant finding is that almost three-quarters of the patients preferred to be called by their first name, even among elderly patients.

According to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology , a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor , has been shown to result in excellent local control at a median follow ...

Amgen announced that the Phase 3 PRIME "203" trial evaluating Vectibix administered in combination with FOLFOX as a first-line treatment of metastatic colorectal cancer failed to meet a secondary endpoint of overall survival.

Treating a common brain tumor with multiple sessions of radiation appears to result in less brain swelling than treating the tumor once with a high dose of radiation, say researchers from the Lombardi Comprehensive Cancer Center at Georgetown University Hospital.

Through in-depth interviews with 30 pediatricians and pediatric oncologists at elite medical centers, the authors discovered that physicians tend to view religion and spirituality pragmatically, considering them resources in family decision-making and in end of life situations, and barriers when they conflict with medical decisions, said lead ...

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

Men whose prostate specific antigen rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international study led by Fox Chase Cancer Center radiation oncologist Mark K. Buyyounouski, M.D., M.S. and presented at the annual meeting of the American Society for Radiation Oncology .

" A patient's socioeconomic status has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new study from Henry Ford Hospital in Detroit.

Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival.

One in three breast cancers that spreads also changes form, according to new research that may explain why some women do not respond to treatment.

Women with a relatively uncommon type of breast cancer are significantly more likely to face its recurrence and spread, but researchers now say these women may benefit from treatment with the breast cancer drug Herceptin.

Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is required to treat existing or potential metastatic cancers.

Treating limited stage small cell lung cancer with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results, opening the door to larger scale investigation, according to new research from The University of Texas M. D. Anderson Cancer Center.

Three-year survival was 100 percent for people with early-stage lung cancer and good lung function who were treated with radical stereotactic radiosurgery using CyberKnife, according to a new study funded by the product's maker.

Clinical researchers at Princess Margaret Hospital have confirmed that patients with oropharyngeal squamous cell cancer harbour a common type of human papilloma virus , but also that such cancers are very sensitive to radiation.

U.S. scientists say they're trying to determine if a NASA imaging technique can predict radiation therapy tissue damage experienced by breast cancer patients.

Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab a 'a 'typically used in combination with chemotherapy.

Nov. 3, 2009 - Alexandra Wilson was just 4 when she was diagnosed with acute lymphocytic leukemia, a cancer affecting blood and blood marrow.

American Society for Radiation Oncology Patients with non-small cell lung cancer treated with preventative brain radiation , significantly decrease their risk of developing brain metastases by more than 50 percent , compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, ...

Main Category: Melanoma / Skin Cancer Also Included In: Pharma Industry / Biotech Industry BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced that the data from its completed Phase 2 clinical study of OncoVEX for the treatment of advanced melanoma has been published ...

Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized study of its kind presented at the plenary session ...

Proton beam therapy can be safely delivered to men with prostate cancer and has minimal urinary and rectal side effects, according to a study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

Patients whose melanoma has spread to one or more lymph nodes face a decreased risk of the deadly skin cancer returning if they have radiation treatment following the removal of the nodes, a new Australian study shows.

After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, according to a randomized 10-year study presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American ...

Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen levels below detectable amounts in prostate cancer patients.

Research published in the November 2009 issue of the Journal of Thoracic Oncology has found that intervals between lung cancer suspicion, diagnosis and treatment may be attributed to health care system discrepancies.

A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer.

E-mail: alain.mange@univ-montp1.fr Received 29 March 2009; Revised 12 August 2009; Accepted 17 September 2009; Published online 26 October 2009.

Main Category: Breast Cancer Also Included In: Cancer / Oncology Article Date: 28 Oct 2009 - 6:00 PDT Cancer Research UK scientists have used a cutting edge microscopy technique to identify genes whose activity could be blocked by drugs to stop the spread of the breast cancer .

What is a radiation oncologist? A radiation oncologist is a physician who is specially trained to treat cancer patients utilizing radiation.